Correlation between linezolid zone diameter and minimum inhibitory concentration values determined by regression analysis.
Linezolid is a new synthetic antibiotic belonging to the oxazolidinone class, available for the therapy of gram-positive infections, caused by methicillin-resistant staphylococci, vancomycin-resistant enterococci and penicillin-resistant pneumococci. The aim of the study was to determine the in vitro activity of linezolid against staphylococci strains and also to determine the relationship between the minimum inhibitory concentration (MIC) and inhibition zone diameter by calculating the regression analysis. We tested one hundred S. aureus isolates, obtained from healthy persons (naso-pharyngeal swabs) during 2005 year. The antibiotic susceptibility of strains was determined by disk diffusion standardized method and by agar dilution method using a multipoint inoculator. The relationship between the diameter of the inhibition zone produced by a linezolid disc impregnated with a fixed amount (30 eg) was determined by regression performed with the least squares method, considering the log2 of the minimum inhibitory concentrations (MICs) as the independent variable and the zone diameter as the dependent variable. The MIC values expressed in logarithmic form are plotted against inhibition zone diameter (arithmetic scale) of the same strain. The activity of linezolid against staphylococci was very good, with MIC 90 of 1 mg/l. All strains were fully sensitive. The regression line for linezolid passes through a continuous series of points that all are approximately located on the a straight line. For each of the MIC values the differences result no greater than 23 mm in diameter sizes were registered. Regression equation was y= -0.188x + 8.048. In conclusion, the regression line analysis calculated for linezolid, demonstrates a significant correlation between MIC values and the inhibition zone diameters obtained by a 30 mg disc.
Dimitriu
G
G
School of Pharmacy, "Gr. T. Popa" University of Medicine and Pharmacy, Iaşi.
Poiata
Antonia
A
Tuchiluş
Cristina
C
Buiuc
D
D
D000081:Acetamides / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D000069349:Linezolid; D008826:Microbial Sensitivity Tests; D009666:Nose / Q000382:microbiology; D023303:Oxazolidinones / Q000627:therapeutic use*; D010614:Pharynx / Q000382:microbiology; D012044:Regression Analysis; D013211:Staphylococcus aureus / Q000187:drug effects*
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid